Cargando…
Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
BACKGROUND: Craniopharyngioma (CP) is rare histologically benign but clinically challenging tumor because of its intimate relationship with the critical structure in the central brain. CP can be divided into two major histologic subtypes: adamantinomatous-type CP (ACP) and papillary-type CP (PCP). A...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684236/ https://www.ncbi.nlm.nih.gov/pubmed/34922552 http://dx.doi.org/10.1186/s12943-021-01468-7 |
_version_ | 1784617577758064640 |
---|---|
author | He, Juan Zeng, Zhen Wang, Yuelong Deng, Jiaojiao Tang, Xin Liu, Fujun Huang, Jianhan Chen, Hongxu Liang, Ruichao Zan, Xin Liu, Zhiyong Tong, Aiping Guo, Gang Xu, Jianguo Zhu, Xiaofeng Zhou, Liangxue Peng, Yong |
author_facet | He, Juan Zeng, Zhen Wang, Yuelong Deng, Jiaojiao Tang, Xin Liu, Fujun Huang, Jianhan Chen, Hongxu Liang, Ruichao Zan, Xin Liu, Zhiyong Tong, Aiping Guo, Gang Xu, Jianguo Zhu, Xiaofeng Zhou, Liangxue Peng, Yong |
author_sort | He, Juan |
collection | PubMed |
description | BACKGROUND: Craniopharyngioma (CP) is rare histologically benign but clinically challenging tumor because of its intimate relationship with the critical structure in the central brain. CP can be divided into two major histologic subtypes: adamantinomatous-type CP (ACP) and papillary-type CP (PCP). Although some genetic aberrations for both categories have been revealed in previous studies, the complete spectrum of genetic changes of this tumor remains unknown. METHODS: In this study, we conducted whole genome sequencing (WGS) on twenty-six CPs including 16 ACPs and 10 PCPs together with their matched blood samples. Somatic variants (SNVs, InDels, SVs and CNVs) were identified and mutational signatures were characterized for each patient. We investigated the impact of a novel CTNNB1 mutant on its protein stability, ubiquitination and Wnt pathway activity. Cell proliferation ability of the CTNNB1 mutant in ACP primary cells was additionally analyzed by CCK8 and colony formation assays. RESULTS: We found that CPs had showed less complexity with fewer somatic mutations compared with malignant tumors. Moreover, mutations in CTNNB1 (68.75% of ACP) and BRAF V600E (70.00% of PCP) are mutually exclusive in ACP and PCP, consolidating that the driving roles of these two genes in ACP and PCP, respectively. A novel mutation in the exon 3 of CTNNB1 which compromised both a transversion and in-frame deletion was identified in ACP. This mutation was experimentally validated to confer β-catenin increased stability by inhibiting its ubiquitination, thus activating Wnt-signaling pathway and promoting cell proliferation. CONCLUSIONS: Whole genome landscape for CP was revealed by WGS analysis, and a novel mutation in the exon 3 of CTNNB1 was identified. This novel mutation activates Wnt-signaling pathway through increasing the stability of β-catenin. Our findings provided us with more comprehensive insight into the spectrum of genetic alterations in CP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-021-01468-7. |
format | Online Article Text |
id | pubmed-8684236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86842362021-12-20 Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing He, Juan Zeng, Zhen Wang, Yuelong Deng, Jiaojiao Tang, Xin Liu, Fujun Huang, Jianhan Chen, Hongxu Liang, Ruichao Zan, Xin Liu, Zhiyong Tong, Aiping Guo, Gang Xu, Jianguo Zhu, Xiaofeng Zhou, Liangxue Peng, Yong Mol Cancer Research BACKGROUND: Craniopharyngioma (CP) is rare histologically benign but clinically challenging tumor because of its intimate relationship with the critical structure in the central brain. CP can be divided into two major histologic subtypes: adamantinomatous-type CP (ACP) and papillary-type CP (PCP). Although some genetic aberrations for both categories have been revealed in previous studies, the complete spectrum of genetic changes of this tumor remains unknown. METHODS: In this study, we conducted whole genome sequencing (WGS) on twenty-six CPs including 16 ACPs and 10 PCPs together with their matched blood samples. Somatic variants (SNVs, InDels, SVs and CNVs) were identified and mutational signatures were characterized for each patient. We investigated the impact of a novel CTNNB1 mutant on its protein stability, ubiquitination and Wnt pathway activity. Cell proliferation ability of the CTNNB1 mutant in ACP primary cells was additionally analyzed by CCK8 and colony formation assays. RESULTS: We found that CPs had showed less complexity with fewer somatic mutations compared with malignant tumors. Moreover, mutations in CTNNB1 (68.75% of ACP) and BRAF V600E (70.00% of PCP) are mutually exclusive in ACP and PCP, consolidating that the driving roles of these two genes in ACP and PCP, respectively. A novel mutation in the exon 3 of CTNNB1 which compromised both a transversion and in-frame deletion was identified in ACP. This mutation was experimentally validated to confer β-catenin increased stability by inhibiting its ubiquitination, thus activating Wnt-signaling pathway and promoting cell proliferation. CONCLUSIONS: Whole genome landscape for CP was revealed by WGS analysis, and a novel mutation in the exon 3 of CTNNB1 was identified. This novel mutation activates Wnt-signaling pathway through increasing the stability of β-catenin. Our findings provided us with more comprehensive insight into the spectrum of genetic alterations in CP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-021-01468-7. BioMed Central 2021-12-18 /pmc/articles/PMC8684236/ /pubmed/34922552 http://dx.doi.org/10.1186/s12943-021-01468-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research He, Juan Zeng, Zhen Wang, Yuelong Deng, Jiaojiao Tang, Xin Liu, Fujun Huang, Jianhan Chen, Hongxu Liang, Ruichao Zan, Xin Liu, Zhiyong Tong, Aiping Guo, Gang Xu, Jianguo Zhu, Xiaofeng Zhou, Liangxue Peng, Yong Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing |
title | Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing |
title_full | Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing |
title_fullStr | Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing |
title_full_unstemmed | Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing |
title_short | Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing |
title_sort | characterization of novel ctnnb1 mutation in craniopharyngioma by whole-genome sequencing |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684236/ https://www.ncbi.nlm.nih.gov/pubmed/34922552 http://dx.doi.org/10.1186/s12943-021-01468-7 |
work_keys_str_mv | AT hejuan characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT zengzhen characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT wangyuelong characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT dengjiaojiao characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT tangxin characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT liufujun characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT huangjianhan characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT chenhongxu characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT liangruichao characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT zanxin characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT liuzhiyong characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT tongaiping characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT guogang characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT xujianguo characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT zhuxiaofeng characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT zhouliangxue characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing AT pengyong characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing |